Medifast (MED) Tops Q4 EPS by 1c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $11.02 -0.18%
Revenue Growth %: -29.3%
Financial Fact:
Cost of sales: 16.42M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -29.3%
Financial Fact:
Cost of sales: 16.42M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q4 EPS of $0.34, $0.01 better than the analyst estimate of $0.33. Revenue for the quarter came in at $62.5 million versus the consensus estimate of $65.01 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Robinhood prices $2B convertible notes offering due 2029
- FirstCash to acquire UK pawn operator Ramsdens for £206 million
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
